← Open Payments lookup

REGAN WOODHAM: Open Payments

NPI 1467064089 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,300 in 166 payments from 19 companies in 2025. Trend: 2023 $2,270 · 2024 $2,898 · 2025 $3,300

Food & beverage: $3,300
CompanyPaymentsAmount
GlaxoSmithKline, LLC.30$496
AstraZeneca Pharmaceuticals LP19$495
Boehringer Ingelheim Pharmaceuticals, Inc.18$384
GENZYME CORPORATION14$295
Regeneron Healthcare Solutions, Inc.14$261
Takeda Pharmaceuticals U.S.A., Inc.11$224
United Therapeutics Corporation9$200
Amgen Inc.12$193
Viatris Specialty LLC7$145
Grifols USA, LLC5$115

Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Tyvaso, NUCALA, OFEV, FASENRA, YUPELRI.

Industry payments across AL — which companies pay providers there.